Phase 4
N=31
Pecto-intercostal Fascial Block (PIFB) for Postop Analgesia Following Sternotomy in Cardiac Surgery Patients
Analgesia · Sternotomy
Bottom Line
View on ClinicalTrials.gov: NCT05676814 ↗Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores — 6.39; 4.22 scores on a scale*hour
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Pecto-intercostal Fascial Block (PIFB) (Drug); PIFB with adjuvants (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Jun 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores |
— | — |
| PRIMARY Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores |
— | — |
| PRIMARY Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores |
— | — |
| PRIMARY Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores |
— | — |
| PRIMARY Area Under the Curve (AUC) Pain Score - Based on Patient-reported Dynamic Numerical Rating Scale (NRS) Pain Scores |
— | — |
| SECONDARY Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest |
5.25; 3.43; 2.67; 3.14; 2.45; 3.5 | — |
| SECONDARY Patient-reported Numerical Rating Scale (NRS) Pain Scores at Rest |
5.25; 3.43; 2.67; 3.14; 2.45; 3.5 | — |
| SECONDARY Average Cumulative Opioid Consumption |
— | — |
| SECONDARY Average Time to First Opioid Administration |
— | — |
| SECONDARY Average Time to Extubation |
276.815; 232.020 | — |
| SECONDARY Duration of Intensive Care Unit (ICU) Admission |
50.620; 51.541 | — |
| SECONDARY Incentive Spirometry Volumes |
2750; 3427.08; 525; 1333.33; 968.06; 1519.44 | — |
| SECONDARY Safety Outcome: Nausea Incidence |
— | — |
| SECONDARY Safety Outcome: Vomiting Incidence |
— | — |
| SECONDARY Safety Outcome: Postoperative Delirium Incidence |
— | — |
| SECONDARY Numeric Rating Scale (NRS) Satisfaction With the Analgesic Regimen |
7.92; 8.88 | — |
Summary
The purpose of this randomized, triple-blinded, prospective, feasibility study is to compare postoperative analgesia provided by Pecto-intercostal Fascial Block (PIFB) when performed with local anesthetic solution with or without perineural adjuvants in patients following cardiac surgery involving sternotomy. The study team hypothesizes that the patients receiving PIFB with bupivacaine with epinephrine, clonidine, and dexamethasone will have lower dynamic pain over the first 36 hours compared to those receiving PIFB with just bupivacaine and epinephrine.
Eligibility Criteria
Inclusion Criteria
- Adults between undergoing cardiac surgery involving sternotomy
Exclusion Criteria
- Patients with any contraindications to regional anesthesia, such as history of allergy to amide local anesthetics or any of the perineural adjuvants
- existing neurologic deficit in the chest wall;
- remaining intubated at the six hour point after block placement
- weight under 50kg
- undergoing emergency surgical procedures or urgent return to the operating room
- active endocarditis or mediastinitis
- moderate to severe right ventricular function before or after cardiopulmonary bypass
- reliance on mechanical circulatory support devices, such as intra-aortic balloon pump or Impella
- reliance on extracorporeal membrane oxygenation
- localized or systemic infection
- chronic use of high dose opioid analgesics (defined as daily use greater than 30 oral morphine milligram equivalents (OMME) for over one month prior to surgery)
- those who are pregnant
Data sourced from ClinicalTrials.gov (NCT05676814). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.